36C24220R0017-001.docx

Contract Opportunity Presolicitation Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE (MM-DD-YYYY)

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field Contract Opportunity Presolicitation Notice Q VSN 2 Genetic & Esoteric Testing 10468-3904 36C24220R0017 01-06-2020 N

SDVOSBC

621511 Department of Veterans Affairs Network Contracting Office 2 James J. Peters VA Medical Center 130 West Kingsbridge Road Bronx NY 10468-3904 Janice Brooks Campbell Janice.Brooks@va.gov VISN 2 South 10468

USA

http://va.gov/ Janice.Brooks@va.gov Janice.Brooks@va.gov Janice.Brooks@va.gov Description of Services The Contractor shall provide a full range of Prognostics, Molecular Diagnostics, and Therapeutic referral laboratory services for the Veterans Integrated Service Network 2, herein after designated as VISN 2 South. VISN 2 South is comprised of the five (5) VA medical center facilities listed below:

JJP VA Medical Center Bronx, NY VA New Jersey Health Care System VA Hudson Valley Healthcare System VA NY Harbor Healthcare System Northport VA Medical Center

1. Basic services shall include the transportation of clinical laboratory specimens to the Contractor’s laboratory(s), performance of analytical testing as defined by the Contractor’s reference test manual, reporting of analytical test results, and consultative services as required to provide the full scope of its laboratory operations for VISN 2 South.

1. The reference laboratory must be licensed/accredited by the College of American Pathologists, the Nuclear Regulatory Commission, and Center for Disease Control, Medicare and/or other state regulatory agencies as mandated by federal and state statutes. In addition, the Laboratory must be certified as meeting the requirements of the Clinical Laboratory Improvement Act of 1988.

Period of performance is estimated as:

Base period: 1 February 2020 – 31 February 2021 Option period 1: 1 February 2021 – 31 February 2022 Option period 2: 1 February 2022 – 31 February 2023 Option period 3: 1 February 2023 – 31 February 2024 Option period 4: 1 February 2024 – 31 February 2025

Solicitation will be posted in 15 Days from this notice.